Crescenta Biosciences Inc. is a small molecule drug discovery company focused on developing novel therapeutic approaches for diseases related to fatty acid metabolism. Our discovery platform is based on a new concept that allows for the manipulation of biological functions associated with “fatty acid interacting proteins” in such a way to correct metabolic imbalance, thus providing broad therapeutic opportunities. By applying this unique platform, we have assembled a portfolio of first-in-class drug candidates for the treatment of diseases with major unmet medical needs, particularly those related to metabolism and aging. Our goal is to advance our pipeline into clinical development and commercialization.    

Learn More  →